30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

DJO Posts 2Q18 Revenue -

DJO Global posted 2Q18 revenue of US $304.8MM, +3.4% vs. 2Q17, and 1H18 revenue of $739.4MM, +5.0% vs. 1H17.

ORTHOWORLD estimates segment sales and growth as follows.

  2Q18  2Q17  $ Change  % Change 
 Joint Reconstruction $71.0  $60.8  $10.2  16.8% 
  Knee $19.2  $16.2  $3.1  19.0% 
  Hip $16.7  $14.6  $2.1  14.2% 
  Extremities $35.0  $30.0  $5.1  16.8% 
 Other* $233.9  $233.9  -$0.1  0.0% 
Total  $304.8  $294.7  $10.1  3.4% 


  1H18  1H17  $ Change  % Change 
 Joint Reconstruction $142.0  $121.0  $21.0  17.3% 
  Knee $38.5  $32.2  $6.3  19.6% 
  Hip $33.4  $29.1  $4.3  14.8% 
  Extremities $70.1  $59.7  $10.4  17.4% 
 Other * $597.5  $583.1  $14.4  2.5% 
Total  $739.4  $704.0  $35.4  5.0% 

*Includes Bracing/Vascular, Recovery Sciences and also International revenue not already attributed to Joint Recon

Revenue by geographic region:

  2Q18  1H18 
 U.S. $217.9  $563.8 
 Ex-U.S. $87.0  $175.6 


DJO had a great quarter and half in Surgical Implants—in shoulders, specifically, citing growth of +19% for the quarter and +20% for the half. (Surgical Implants comprises hips, knees, shoulders, elbows, bone cement, etc. Please keep in mind that ORTHOWORLD estimates reflect a portion of International revenue from joint reconstruction products that is added to DJO’s Surgical Implant segment reporting. We always welcome comments on our estimates.)

The company commenced a series of product launches at the end of 2Q, with more planned in 3Q to fuel double-digit growth in hip and knee as well as the entire business. As noted in the 1Q18 call, DJO planned for seven surgical implant launches in 2018, with six slated for hip/knee.

Leadership highlighted continued sustainable value delivery from the company’s transformation efforts originally announced in the 2016 call. As planned, the company is on track to realize 7% to 10% in annual cost reductions by end of this year.

Sources: DJO Global, Inc.; ORTHOWORLD estimates

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.